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Abstract
Background Bile duct injury (BDI) is a dreaded compli-
cation of cholecystectomy, often caused by misinterpreta-
tion of biliary anatomy. To prevent BDI, techniques have
been developed for intraoperative assessment of bile duct
anatomy. This article reviews the evidence for the different
techniques and discusses their strengths and weaknesses in
terms of efficacy, ease, and cost-effectiveness.
Method PubMed was searched from January 1980
through December 2009 for articles concerning bile duct
visualization techniques for prevention of BDI during
laparoscopic cholecystectomy.
Results Nine techniques were identified. The critical-view-
of-safety approach, indirectly establishing biliary anatomy,
is accepted by most guidelines and commentaries as the
surgical technique of choice to minimize BDI risk. Intraop-
erative cholangiography is associated with lower BDI risk
(OR 0.67, CI 0.61–0.75). However, it incurs extra costs,
prolongs the operative procedure, and may be experienced as
cumbersome. An established reliable alternative is laparo-
scopic ultrasound, but its longer learning curve limits
widespread implementation. Easier to perform are chole-
cystocholangiography and dye cholangiography, but these
yield poor-quality images. Light cholangiography, requiring
retrograde insertion of an optical fiber into the common bile
duct, is too unwieldy for routine use. Experimental tech-
niques are passive infrared cholangiography, hyperspectral
cholangiography, and near-infrared fluorescence cholangi-
ography. The latter two are performed noninvasively and
provide real-time images. Quantitative data in patients are
necessary to further evaluate these techniques.
Conclusions The critical-view-of-safety approach should
be used during laparoscopic cholecystectomy. Intraopera-
tive cholangiography or laparoscopic ultrasound is rec-
ommended to be performed routinely. Hyperspectral
cholangiography and near-infrared fluorescence cholangi-
ography are promising novel techniques to prevent BDI
and thus increase patient safety.
Keywords Cholecystectomy  CBD  Common bile duct 
Complications
Abbreviations
BDI Bile duct injury
LC Laparoscopic cholecystectomy
CBD Common bile duct




NIRF-C Near-infrared fluorescence cholangiography
Cholecystectomy is one of the most frequently performed
operations in the Western world, with over 750,000 yearly
in the United States alone [1]. Bile duct injury (BDI) is a
dreaded complication of cholecystectomy. When the
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laparoscopic technique was introduced in the early 1990s
an increase of BDI was noted from approximately 0.2% to
about 0.5% [2].
The burden of BDI on patients is considerable. Rein-
terventions through surgical, endoscopic, or radiologic
procedures in specialist centers are frequently necessary
[3–5]. BDI has low but finite short- and long-term mortality
rates [6, 7]. A recent study reported that BDI had a sig-
nificant negative effect on quality of life even 10 years
after the event [8]. BDI is also associated with substantial
financial burden for the health-care system: A British study
calculated an average cost of 108,000£ (*175,000 $US)
for major BDI (hospital and society costs). In addition, BDI
is frequently grounds for malpractice litigation [7, 9, 10].
During laparoscopic cholecystectomy the primary cause
of BDI is an error of visual perception (in 71–97% of
cases), not insufficient technical skill of the surgeon
[11, 12]. Factors that impede visual assessment and
increase the risk of BDI include past or ongoing inflam-
mation, variant ductal anatomy, and limited surgical
experience [2, 13].
To prevent BDI, systematic safety interventions have
been developed to provide insight into the biliary anatomy
during cholecystectomy. For such an intervention to be
effective, it first needs to be safe for patients and personnel.
Second, it needs to be simple to use and easy to interpret
since a wide range of surgeons and residents perform
cholecystectomies. Third, considering the large volume of
cholecystectomies and the continuous pressure to keep
health-care expenditures under control, extra operating
time, material expenses, and personnel expenses need to be
kept to a minimum.
This review aims to provide an overview of the different
modalities for intraoperative assessment of biliary anatomy
during cholecystectomy and discuss their strengths and
weaknesses.
Methods
The electronic database PubMed and the Web of Science
were searched from January 1980 through November 2010
for English language articles concerning techniques of
intraoperative assessment of biliary anatomy for prevention
of BDI. The following search terms were used: ‘‘bile duct
injury,’’ ‘‘cholecystectomy,’’ ‘‘intraoperative cholangiog-
raphy,’’ ‘‘cholangiography,’’ ‘‘bile duct visualization,’’
‘‘bile duct imaging,’’ and ‘‘bile duct mapping.’’ The ref-
erence lists of the selected articles were also searched.
To portray the protective effect of conventional intra-
operative cholangiography (IOC) on BDI in a forest plot,
all studies of more than 10,000 patients were selected that
explicitly compared the incidence of BDI in (laparoscopic)
cholecystectomy with IOC to that without IOC. Studies
that compared only the routine use of IOC with selective
use were not included in the forest plot.
Microsoft Office Excel 2003 (Microsoft, Redmond,
WA, USA) and SPSS v16.0 for Windows (SPSS Inc.,
Chicago, IL, USA) were used for the statistical analysis
and to create the forest plot.
Results
The identified studies on the different imaging modalities
are portrayed in Table 1.
Critical view of safety (CVS)
Although CVS is not an imaging modality per se, the
operative technique plays a major role in establishing the
anatomical orientation of the bile ducts and therefore needs
to be discussed in this review.
Already in 1995, Strasberg et al. [14] described the
‘‘critical view of safety’’ (CVS) approach. Calot’s triangle
is dissected to achieve the following: First, one third of the
gallbladder must be dissected free from the liver bed.
Second, the triangle of Calot must be cleared (with liver
segment V visible through the window). Third, the cystic
artery and cystic duct must be the only two tubular struc-
tures remaining between the gallbladder and the hepa-
toduodenal ligament. In some cases, the cystic artery is
diathermically dissected close to the gallbladder, in which
case only the cystic duct remains to form the CVS. It is not
necessary or recommended that the CBD be visualized. In
this manner, the bile duct remaining can be none other than
the cystic duct.
Achievement of the CVS is recorded in the operation
report, preferably augmented by laparoscopic video or
photographic images [15]. Failure to achieve the CVS is an
absolute indication for conversion or additional bile duct
imaging.
Four series, totaling close to 4,500 patients, have been
published in which cholecystectomies have explicitly been
performed using the CVS technique [16–19]. All four
series showed very low BDI rates (0–0.03%). A Japanese
review article noted a decrease in self-reported BDI during
laparoscopic cholecystectomy from 0.77% in 2005 to
0.58% in 2007 and suggested that the increased imple-
mentation of the CVS technique played a role in this
decrease [20]. Strasberg [21] mentioned the lack of level 1
evidence that the CVS approach prevents bile duct injury in
his recent commentary.
Although undoubtedly a great step toward safer chole-
cystectomy, it is unclear whether the CVS alone is suffi-
cient as a technique to minimize the risk of BDI. Our own
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Table 1 Evidence on the different modalities for intraoperative assessment of the biliary tree
Primary author No. of
patients
Study description Outcome
CVS—patient series of LCs using the CVS
Rawlings [19] 54 All patients (suffering from biliary colic) underwent single-port
LC using the CVS technique.
CVS in all patients;
0 BDI, 0 bile leaks
Sanjay [18] 447 All patients (acute pathology) underwent LC using the CVS
technique.
CVS achieved in 388 (87%);
0 BDI, 0 bile leaks
Avgerinos [16] 1,046 All patients underwent LC using the CVS technique. CVS achieved in 998 (95%);
0 BDI, 5 bile leaks (0.5%)
Yegiyants [17] 3,046 Administrative data of an institution in which CVS was standard.
Injuries requiring surgical repair were identified.
CVS percentage not assessed;
1 BDI (0.03%), bile leaks not assessed
IOC—studies [ 10,000 patients on the association between IOC and BDI
Z’graggen [34] 10,174 1992–1995; analysis of LCs in a prospective database for which
numerous Swiss institutions provide data (SALTS).
OR for BDI using IOC = 0.97 (95% CI
0.44–2.18), unadjusted for confounders
Flum [32] 30,630 1991–1998; Washington State Hospital Discharge Database searched
for CBD repair codes \90 days after LC.
OR for BDI using IOC = 0.63 (95% CI
0.40–0.90), adjusted for confounders
Hobbs [30]a 33,309 1988–1998; Western Australia Data Linkage System was searched in
different ways for patients with complications. Medical files of
these patients were assessed in detail.
OR for BDI using IOC = 0.68 (95% CI
0.42–1.03), adjusted for confounders
Flum [31] 1,570,361 1992–1999; US Medicare data was searched for codes for CBD
repair within 1 year after cholecystectomy.
OR for BDI using IOC = 0.58 (95% CI
0.44–0.72), adjusted for confounders
Waage [33] 152,776 1987–2001; Swedish Inpatient Registry searched for codes for CBD
repair within 1 year after cholecystectomy.
OR for BDI using IOC = 0.75 (95% CI
0.59–0.92), adjusted for confounders
Giger [35]b 31,838 1995–2005; analysis of LCs in a prospective database for which
numerous Swiss institutions provide data (SALTS).
OR for BDI using IOC = 1.14 (95% CI
0.76–1.70), unadjusted for confounders
LUS—patient studies on LUS during LC
Machi [44] 2,159 Review of 12 studies (from before 1999) comparing LUS to IOC
during LC.
Success of LUS and IOC 88-100%; BDI
not assessed
Catheline [45] 600 All patients underwent LCs with LUS, 498 also underwent IOC. LUS and IOC equal success; LUS faster
(10 vs. 18 min, P = 0.001) BDI not
reported
Kimura [49] 183 All patients underwent LCs with LUS and IOC. LUS success 95%; IOC success 96%; 0
BDI; 1 bile leak after choledochotomy
Tranter [54] 367 All patients underwent LC with LUS. LUS success 99%; BDI not reported
Biffl [46] 844 Nonrandomized comparison between LC with LUS (n = 248) and
without LUS (594).
Without LUS: 11 BDI (1.9%); routine
LUS: 0 BDI (P = 0.04)
Catheline [47] 900 All patients underwent LCs with LUS and IOC. LUS success 100%; IOC success 85%;
BDI not reported
Tranter [55] 135 All patients underwent LCs with LUS and IOC. LUS success 97%, IOC success 90%; BDI
not reported
Onders [52] 256 Description of one surgeon’s experience with LUS. Increase in use of LUS from 29% in 2001
to 77% in 2004; 0 BDI
Machi [50] 200 All patients underwent LC with LUS. LUS success in 97%; 0 BDI, 0 bile leaks
Perry [53] 236 All patients underwent LC with LUS. LUS success in 95%; 0 BDI; 0 bile leaks
Hakamada [48] 644 Comparison of outcome before (n = 368) and after (n = 276)
introduction of routine LUS.
Without LUS: 4 BDI (1.1%); routine LUS:
0 BDI (P = 0.08)
Machi [51] 1,381 Prospective multicenter series of LC with LUS. LUS success 98%; 0 BDI; 3 leaks (0.2%)
CCC—patient studies on CCC during LC
Wills [58] 76 Randomized controlled trial between IOC (n = 36) and CCC
(n = 40) during LC.
IOC success in 100%, CCC in 72%
(P \ 0.001); CCC images of poor quality
Daoud [59] 325 Nonrandomized comparison between IOC (n = 35) and CCC
(n = 290).
IOC success 83%, CCC success 86%
Glattli [60] 69 Nonrandomized comparison between IOC (n = 38) and CCC
(n = 31).
IOC success 92%, CCC success 48%; CCC
images of inferior quality
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data show occurrence of major BDI even after the CVS
approach was adopted (unpublished). Also, major BDI
continues to occur in the Netherlands despite increasing
adoption of the CVS technique [4].
In spite of the lack of level 1 evidence, virtually all
recent reviews, guidelines, and commentaries advocate the
CVS technique [22–24]. Without an eligible alternative,
the CVS should be regarded as the gold standard among
operative techniques for assessment of biliary anatomy
during laparoscopic cholecystectomy.
Intraoperative cholangiography (IOC)
Intraoperative cholangiography (IOC) is the most fre-
quently applied technique for intraoperative assessment of
the biliary anatomy. After dissection in Calot’s triangle, the
Table 1 continued
Primary author No. of
patients
Study description Outcome
Fox [61] 113 All patients underwent LC with CCC. CCC was successful in 81%
Koksal [62] 40 All patients underwent LC with CCC. CCC was successful in 90%
Moont [63] 97 All patients underwent LC with CCC. CCC was successful in 85%
Young [64] 194 All patients underwent LC with CCC. CCC was successful in 81%
Holzman [65] 60 Patients underwent ‘‘partial CCC’’ with the Kumar clamp. Kumar CCC was successful in 83%
Kumar [66] 50 Patients underwent ‘‘partial CCC’’ with the Kumar clamp. Kumar CCC was successful in 98%
Dye cholangiography—patient series on dye cholangiography during LC
Pertsemlidis
[67]
18 Indocyanine green (ICG) was intravenously administered to patients
undergoing LC.
Cystic duct and CBD colored green in all
patients. No images provided
Sari [68] 46 Blue dye was injected into the gallbladder during LC. Cystic duct and CBD colored blue in
43/46 patients
Xu [69] 20 Blue dye was injected into the gallbladder during LC. Extrahepatic bile ducts colored blue in
18/20 patients. No images provided
Light cholangiography—patient series
Xu [69] 16 Optical fiber led into the CBD with a duodenoscope during LC. CBD
cannulation successful in 13/16 patients.
CBD visualized in 13 cases, cystic duct
only in 4 cases. No images provided
Passive infrared cholangiography—animal study
Liu [70] 6 pigs Room temperature saline was infused into the biliary tract. Images
were taken with an infrared camera.
Infrared images correlated well with
IOC. Artificial stones and BDI detected
Near-infrared cholangiography (NIRF-C)—patient studies on NIRF-C
Mitsuhashi [73] 5 Open cholecystectomy after intravenous infusion of ICG. A NIRF
camera system was used to capture images.
Fluorescence observed in the liver,
gallbladder, and bile ducts of all
patients
Ishizawa [71] 1 First laparoscopic experience with NIRF-C during cholecystectomy. Fluorescence observed in cystic duct and
CBD
Ishizawa [74] 10 Open cholecystectomy after intravenous infusion of ICG. A NIRF
camera system was used to capture images.
Cystic duct and CBD were identified in
9/10 patients using NIRF-C
Aoki [75] 14 LC after intravenous administration of ICG. CBD-cystic duct junction identified in
10/14 patients
Tagaya [76] 12 LC after intravenous ICG. Hepatoduodenal ligament was compressed
with plastic device for improved exposure.
The CBD-cystic duct junction was
identified in all patients
Ishizawa [86] 52 LC after intravenous ICG. CBD-cystic duct junction identified in
50/52 patients
Hyperspectral cholangiography—animal studies
Zuzak [82] 1 pig A laparoscopic near-infrared, hyperspectral imaging system was used
to assess bile duct anatomy in a pig.
Bile ducts, arteries, and veins all have
unique reflectance spectra
Livingston [81] 8 pigs Characteristics of different types of tissue were assessed using a
laparoscopic hyperspectral imaging system.
Bile ducts, arteries, and veins all have
unique reflectance spectra
LC laparoscopic cholecystectomy, CVS critical view of safety, BDI bile duct injury, IOC intraoperative cholangiography, LUS laparoscopic
ultrasound, CCC cholecystocholangiography, NIRF-C near-infrared fluorescence cholangiography, CBD common bile duct, ICG indocyanine
green, OR odds ratio
a Includes data set of Fletcher et al. [84]
b Includes data set of Krahenbuhl et al. [85]
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surgeon identifies and cannulates the cystic duct at the
junction with the gallbladder. Radiographic contrast is then
injected into the cystic duct and (subtracted) X-ray fluo-
roscopy images are obtained. The advent of dynamic
fluoroscopy has improved the speed with which IOC can be
performed and yields a series of high-resolution images
that more accurately depict the biliary anatomy [25, 26].
IOC identifies whether the cannulated duct is indeed the
cystic duct or mistakenly the CBD. In the latter case, the
ductotomy may be repaired by inserting a T-tube and
complete transection of the CBD is prevented. IOC may
also identify abnormal biliary anatomy such as an acces-
sory cystic duct or an aberrant right hepatic duct. IOC
allows early detection of BDI, in which case a blush of
contrast originating from the biliary tract or clips placed
over the common or hepatic bile ducts may be seen.
Quoted success rates are generally around or up to 90%
[27, 28].
It has been calculated that a sufficiently powered, ran-
domized controlled trial to assess the impact of IOC on
BDI would need to include more than 30,000 patients [29].
As a result, the evidence of the role of IOC in the pre-
vention of BDI consists mainly of population-based studies
(Table 1). Figure 1 shows a forest plot of the six largest
population-based studies (each [10,000 patients) [30–35]
that compare the incidence of BDI in cholecystectomies
explicitly performed using IOC to that in cholecystecto-
mies explicitly performed without IOC. From this meta-
analysis, the OR for BDI when using IOC was 0.67
(range = 0.61–0.75). When the studies were weighted
according to actual size rather than the square root of the
size, the OR was 0.60 (range = 0.52–0.70). Although the
strongest evidence available, these studies are prone to bias
and confounders as they rely heavily on administrative data
of heterogeneous groups. For example, in these studies
IOCs that were performed only because BDI was already
suspected or observed, were included in the ‘‘IOC group.’’
For this reason, the number of BDIs that occurred when
IOC was used could have been substantially higher than the
true incidence.
Perhaps even more relevant than whether IOC in itself is
useful is the question of whether it should be performed
routinely or selectively. Metcalfe et al. [36] reviewed eight
retrospective series of laparoscopic cholecystectomies
(total of 6,024 patients) with routine IOC and nine series
(3,268 patients) with a selective IOC policy. In this
underpowered study, the rates of complete CBD transec-
tion were not significantly different, although a larger
proportion of BDI was identified intraoperatively when
routine IOC was used. Flum et al. [31], in their analysis of
1.5 million patients, found a lower incidence of BDI with
surgeons who used IOC routinely: 0.43% vs. 0.51–0.54%
(P \ 0.001).
An important limitation of all the mentioned studies is
that the cholecystectomies described took place mostly in
the 1990s. During this era, the CVS technique was not yet
widely implemented and therefore the studies can provide
no information on the added value of IOC when the CVS
technique is used. In our university hospital we retrospec-
tively evaluated the implementation of a routine IOC pol-
icy in a population in which CVS was already the standard
of care. We found 8/421 (1.9%) major BDIs before
implementation of routine IOC versus 0/435 cholecystec-
tomies after implementation of routine IOC (P = 0.004)
(personal data). Although the CVS was the standard of care
for all these patients, these data are limited in its retro-
spective nature.
In an editorial, Talamini [37] rightly pointed out that if
the association between IOC and BDI is accepted to be
causal, this will ‘‘radically alter the current practice of
cholecystectomy.’’
Notwithstanding the association of IOC with lower BDI
rates, it has several disadvantages which impede routine
implementation. Cystic duct cannulation can be challeng-
ing, especially when it involves a short, thin, or brittle
cystic duct, and the reported extra time needed for IOC is
10–27 min [38–40]. Special attention should be paid to the
learning curve for interpreting IOC, as some studies report
high proportions of incorrectly interpreted cholangiograms.
For example, Way et al. [11] demonstrated that 34/43
(79%) routine cholangiograms that showed BDI were
incorrectly interpreted. The radiation received during IOC
is only around 0.18 mSv and represents a less than 0.001%
Fig. 1 Forest plot of protective effect of IOC on BDI during
cholecystectomy [30–35]. OR odds ratio, BDI bile duct injury, IOC
intraoperative cholangiography. *Unadjusted OR; **The data set of
Fletcher et al. [84] is included in the study by Hobbs et al. [30].
***The data set of Krahenbuhl et al. [85] is included in the study by
Giger et al. [35]. Studies were weighted by the square root of the
study size. Results are plotted on a natural logarithmic scale
Surg Endosc (2011) 25:2449–2461 2453
123
lifetime added risk of developing cancer [41]. Radiation
exposure is therefore no argument against routine use of
IOC in the adult population.
Another advantage of IOC is that the learning curve is
generally short: a success rate of 95% was reached in an
institution of eight supervising surgeons after 46 procedures
[42]. Our own data, too, indicate a short learning curve: a
success rate of 90% was reached in the first 3 months after
implementation of routine IOC (personal data).
Whether routine IOC is cost effective depends on the
estimated cost of IOC, the reduction of the BDI rate, and
the cost to repair a BDI, patient death, and malpractice
litigation. Flum et al. [43] entered varying estimates into
cost-effectiveness models and concluded that if the rela-
tionship between IOC and lower BDI is indeed causal,
routine application of IOC is cost effective.
In summary, there is a well-established relationship
between IOC and lower incidence and increased early
detection of BDI. It should be taken into account that these
data are from before the CVS era and might not be
extrapolated. Also, the sometimes cumbersome and time-
consuming procedure limits the routine use of IOC in
clinical practice.
Laparoscopic ultrasound (LUS)
An alternative to radiography for intraoperative assessment
of biliary anatomy is laparoscopic ultrasonography (LUS).
Laparoscopic flexible multifrequency ultrasound transduc-
ers with a Doppler flow detection system visualize tissue
4 cm in length and 6 cm in depth. The extrahepatic bile ducts
may be scanned in the transverse and longitudinal planes.
LUS can identify the CBD, the bifurcation cystic duct-CBD,
hepatic artery, portal vein, inferior vena cava, and ampulla.
In 1999, Machi et al. [44] reviewed 2,059 patients who
underwent both LUS and IOC and found a success rate of
over 90% for both modalities. In the following years, extra
evidence has been amassed on the value of LUS [45–55]
(Table 1). Virtually all these studies report success rates of
more than 95%, comparable to or higher than that of IOC.
The intrapancreatic and intrahepatic parts of the biliary
system are not always accurately depicted with LUS. The
time needed for LUS ranges between 5 and 10 min.
One retrospective cohort study achieved significance in
the main end point of BDI: 11/594 without LUS vs. 0/248
with LUS (P = 0.04) [46]. A prospective multicenter
cohort study by Machi et al. [51] reported no BDI and only
three bile leaks in 1,381 patients. The study of the ability of
LUS to detect BDI intraoperatively is limited to two studies
in pigs in which it successfully identified wrongfully
placed clips and complete transections [56, 57].
All evidence shows excellent results with LUS in
delineating the biliary anatomy. The advantages of LUS
over IOC are the shorter procedure time, its noninvasive
nature, and lack of use of radiation. Furthermore, it may be
performed prior to dissection in Calot’s triangle and repe-
ated in uncertain cases. One of the main drawbacks of LUS
is the reported long learning curve. Strangely, little data
about this learning curve are available. Machi et al. [51]
suggested that it takes 50–100 operations before one can
successfully apply LUS. Although no efficient technique
should be discarded simply because it takes time to learn,
this does pose a limitation for the widespread implemen-
tation of LUS.
Cholecystocholangiography (CCC)
Cholecystocholangiography (CCC) is performed by
injecting radiographic contrast directly into the gallbladder.
An alternative instrument for ‘‘partial’’ CCC is the
so-called ‘‘Kumar clamp,’’ which is placed across the base
of the gallbladder, after which radiographic contrast is
injected into Hartmann’s pouch.
The only randomized controlled trial found a lower
success rate of CCC compared to IOC (72 vs. 100%,
P = 0.0005) [58]. Also, CCC yielded inferior image
quality and a 2.3 times longer radiation exposure. In
comparative studies, Daoud et al. [59] reported comparable
success rates for CCC and IOC, while Glattli et al. [60]
found a very low success rate of 36% for CCC versus 90%
in IOC. In general, success rates CCC series vary between
72 and 90% [61–64]. CCC reduces operative time com-
pared to IOC [58]; times necessary to perform CCC are
quoted as between 2 and 14 min [59, 61, 64]. The Kumar
clamp for ‘‘partial’’ CCC was used in only two series, with
success rates of 98 and 83% [65, 66]. The above-mentioned
studies are further described in Table 1.
CCC is a simple technique with a steep learning curve
[61], requires no cystic duct cannulation, and is faster than
IOC. However, the success rate is low (*80%), and even
when successful, the image quality is often poor. Of extra
concern is the report of hypotension and gallbladder per-
foration when the gallbladder is distended [58]. Based on
these arguments, CCC is not recommended as a standard
procedure for cholangiography. An exception may be
partial CCC using the Kumar clamp, as this instrument
allows the injection of contrast under higher pressure and
needs to fill only part of the gallbladder. However, this
instrument has yet to prove its superiority to standard IOC.
Dye cholangiography
It has been reported that intravenous injection of high doses
of indocyanine green (ICG) in patients undergoing LC
color the extrahepatic bile ducts dark blue for 2 h [67]. Sari
et al. [68] injected methylene blue directly into the
2454 Surg Endosc (2011) 25:2449–2461
123
gallbladder and were able to identify the gallbladder, cystic
duct, and CBD in 43/46 cases (93%). Xu et al. [69]
reported a success rate of 90% (18/20) (see also Table 1).
With dye cholangiography one has the advantage of
being able to visualize the bile ducts prior to dissection.
The technique is reasonably safe, although extravasation of
the dye is not easily washed away and may obscure the
view of the surgeon. The evidence for its effectiveness is
limited. Xu et al. [69] indicated that the images obtained
were of low resolution. None of the mentioned studies
provide convincing images or quantitative data in support
of the use of dye cholangiography. From a technical per-
spective, dyes in the visible light spectrum (380–600 nm)
may not exhibit the necessary penetration necessary for a
successful cholangiography, especially when Calot’s tri-
angle is filled and surrounded by fatty tissue or fibrosis
resulting from a surpassed inflammatory process. This
presents a serious limitation because it is in these particular
cases that cholangiography has the greatest value.
Light cholangiography
Xu et al. [69] described an experimental technique called light
cholangiography. An optic fiber is endoscopically passed up
through the papilla of Vater and illuminates the extrahepatic
duct system. Unfortunately, no images are provided, limiting
the readers’ ability to make a judgment on its clear merits.
Even if shown to be effective, light cholangiography
done in this manner may be difficult to introduce as a
routine procedure during laparoscopic cholecystectomy
because it requires endoscopy with retrograde maneuvering
of the optical fiber. Besides being time-consuming, this
procedure is potentially hazardous, considering the repor-
ted morbidity and mortality associated with ERCP.
Passive infrared cholangiography
Liu et al. [70] experimented with a passive infrared camera.
In nine pigs they infused room temperature saline or warm
saline into the biliary tract, which contrasted with body
temperature so that the biliary tract could be delineated
(Fig. 2). Also, artificially created BDI and stones could be
identified with this technique.
This method, which uses the brilliantly simple principle
of small temperature differences, bypasses the ionizing
radiation of IOC and can therefore take place repeatedly
and in real time. However, it works only by direct infusion
into the biliary system, as intravenous infusion would result
in regression to body temperature within seconds. More-
over, the temperature of the saline within the bile duct may
regress during the procedure necessitating repetitive
injections. Therefore, infrared cholangiography is regarded
as a suboptimal technique in the operating theatre.
Near-infrared fluorescence cholangiography (NIRF-C)
In the past few years a new imaging modality has been
tested for bile duct visualization: near-infrared fluorescence
cholangiography (NIRF-C) [71]. This technique uses a
laser to excite fluorescent agents and an imaging filter to
register the light (of a slightly higher wavelength) that is
subsequently emitted. Light in the NIRF spectrum
(*800 nm) has optimal penetration and minimal absor-
bance and scattering in human tissue. Fluorophores cleared
by the liver, such as indocyanine green (ICG) and IRDye
800CW (LI-COR Biosciences, Lincoln, NE), may be
administered intravenously or directly into the biliary
system for imaging purposes.
After preliminary animal studies [72], NIRF-C has been
used in a small number of patients since 2008 in open and
laparoscopic (Fig. 3) cholecystectomy [71, 73–76]. Fluo-
rescent signal was detected in the bile ducts of most
patients, but the images were not very clear and had limited
resolution. These studies are listed in Table 1. Figueiredo
et al. [77] published high-quality images of detection of
BDI in a mouse model, although their relevance was lim-
ited because of the absence of periductal fat in the mouse.
Very recently, Ishizawa et al. [78] published a larger
series of 52 patients in whom laparoscopic near-infrared
fluorescence images of a higher resolution than in a previous
series were achieved. Eight preoperatively diagnosed
accessory bile ducts were also visualized by NIRF-C.
Fig. 2 Passive infrared cholangiography in a porcine model depict-
ing leakage of room temperature saline from the common bile duct
(CBD) [70] (with permission from Springer Science ? Business
Media,  2008)
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Although the authors, in a letter to the editor, stated that ICG
is an excellent fluorophore, novel improved fluorophores
will probably further increase the quality and resolution of
the images. This is necessary to decrease the potential for
misinterpretation of the fluorescence images, which is vital
for widespread implementation of safety measures.
A multispectral NIRF imaging system, as recently
described by Themelis et al. [79], simultaneously acquires
real-time color and NIRF images of the operative field. A
possible drawback of fluorescence imaging is the limited
penetration depth. However, penetration up to 3 cm
through medium resembling human adipose tissue has been
described [80]. This depth is sufficient to visualize struc-
tures in Calot’s triangle. NIRF-C is still in its experimental
stage and images acquired are not as informative as IOC.
However, properly developed using high-quality cameras
and bile-cleared fluorophores, NIRF-C has the potential to
be a simple-to-perform, easy-to-interpret, radiation-free,
and personnel-sparing bile duct visualization technique.
Hyperspectral cholangiography
Livingston et al. [81] and Zuzak et al. [82] investigated the
use of hyperspectral cholangiography in pigs. This method
relies on different absorption and reflection patterns of
different tissue (not upon excitation and emission as in
fluorescence). The authors differentiate between gallblad-
der tissue and vascular tissue in pigs with a sensitivity and
specificity of 98% [81]. Also, they processed the data into
images that delineate the cystic duct in the hepatoduodenal
ligament (Fig. 4) [82].
Hyperspectral cholangiography is appealing as it requires
no exogenous contrast agent at all. Preliminary studies in
pigs may be misleading as the porcine biliary system is often
less obscured by fibrosis than is the human system. Valida-
tion studies in humans will need to take place before
hyperspectral cholangiography may be considered a poten-
tial modality for intraoperative visualization of bile ducts.
Discussion
This article has provided an overview of the different
modalities for intraoperative assessment of biliary anat-
omy, summarized in Table 2. The critical-view-of-safety
(CVS) approach is considered the gold standard surgical
technique to prevent BDI. As of yet, only a few published
series were found in which achievement of CVS was
specifically appraised. Although these studies suggest the
protective effect of the CVS approach, future studies are
necessary to appraise the effect of the CVS technique on
BDI. Without an eligible alternative, and based on world-
wide consensus, CVS should be regarded as the gold
standard among operative techniques for assessing the
biliary anatomy during laparoscopic cholecystectomy.
Fig. 3 Near infrared fluorescen cholangiography during laparoscopic
cholecystectomy [78]. A Cystic duct running parallel to common
hepatic duct, B isolation of cystic duct from anterior side of Calot’s
triangle, C isolation of cystic duct from posterior side of Calot’s
triangle, D closure of cystic duct (with kind permission from John
Wiley and Sons Ltd  2010, all rights reserved)
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Level 1 studies on conventional IOC have not been
published [83], but the consistent large-cohort studies
warrant a grade B recommendation. Further research will
need to show the added value of IOC as the CVS
technique gains acceptance. The inherent disadvantages
of IOC cannot be denied: sometimes technically chal-
lenging cystic duct cannulation, need for X-ray equip-
ment, prolonged operation time, and additional costs.
Any developments in reducing these challenges, e.g.,
improvement in technology for the cannulation tech-
nique, would help the general surgeon accept performing
routine IOC during cholecystectomy. Also, an appropri-
ate financial incentive to perform IOC needs to be pro-
vided by the health-care insurance system to ensure
regular use of this technique.
Many ‘‘outcome’’ studies (level 2c evidence [83]) sup-
port laparoscopic ultrasound (LUS) for prevention of BDI.
The outcome is generally excellent, thus warranting a
grade B recommendation. It should be kept in mind that the
reported studies were executed in dedicated centers with
experienced surgeons. As a consequence, their results
cannot be automatically extrapolated to general surgical
practices worldwide. However, in trained hands, LUS is at
least as effective as IOC in defining biliary anatomy, and
does so in less time and radiation-free. Failure of LUS to
achieve wider acceptance probably lies within the pre-
sumed long learning curve.
Cholecystocholangiography, dye cholangiography,
and light cholangiography may be dismissed as valid
modalities for bile duct visualization. They either have too
low a success rate, yield inferior images, or are too
unwieldy for routine implementation. Passive infrared
cholangiography may also prove too impractical for large-
scale utilization.
The most promising novel developments in the field of
bile duct visualization are NIRF-C and hyperspectral
cholangiography. The main points to be proven in the
future are whether they can provide sufficient anatomical
resolution through the fatty fibrous tissue in Calot’s tri-
angle. With the development of more sensitive charge-
coupled device camera systems and superior clinical-
grade NIR fluorophores, these imaging modalities
may provide the ideal tool for intraoperative bile duct
imaging.
This review has focused solely on bile duct visualization
for prevention and early detection of BDI. A second
function of bile duct visualization is the detection of CBD
stones during surgery. IOC and LUS are currently the only
proven modalities for this clinical purpose. Some surgeons
assess for stones only if there are clinical symptoms of
cholestasis or abnormal liver function tests indicative of
cholestasis, in which case a routine bile duct visualization
modality does not necessarily need to convey information
on the presence of stones.
In summary, the search is still ongoing for an optimal
technique for intraoperative assessment of biliary anatomy
that is safe, easy to perform, simple to interpret, personnel-
sparing, cheap, and radiation-free. For now, we recommend
that all surgeons use the critical-view-of-safety approach.
Based on the available literature, it is recommended that
intraoperative cholangiography or laparoscopic ultrasound
of the biliary tree be performed routinely (grade B recom-
mendation). In the future, hyperspectral cholangiography




hyperspectral image of the
hepatoduodenal ligament in live
anesthetized pigs. B An artery
indicated by spectra with broad
oxyhemoglobin peak and a
small water peak at 970 nm.
C A vein is identified by spectra
containing a deoxyhemoglobin
shoulder, a broad
oxyhemoglobin peak, and a
small water peak. D The
common bile duct is associated
with spectra containing a lipid
shoulder and a prominent water
peak [82] (with permission from
Elsevier Inc.,  2008)
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superior techniques for intraoperative visualization of the
biliary anatomy.
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